首页> 外文OA文献 >Expression of a Distinct Set of Chemokine Receptors in Adipose Tissue-Derived Stem Cells is Responsible for In Vitro Migration Toward Chemokines Appearing in the Major Pelvic Ganglion Following Cavernous Nerve Injury
【2h】

Expression of a Distinct Set of Chemokine Receptors in Adipose Tissue-Derived Stem Cells is Responsible for In Vitro Migration Toward Chemokines Appearing in the Major Pelvic Ganglion Following Cavernous Nerve Injury

机译:一组不同的趋化因子受体在脂肪组织干细胞中的表达是负责向海绵状神经损伤后主要骨盆神经节中趋化因子的体外迁移。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionAdipose tissue-derived stem cells (ADSCs) herald tremendous promise for clinical application in a wide range of injuries and diseases. Several preclinical reports demonstrate their efficacy in the treatment of cavernous nerve (CN) injury-induced erectile dysfunction in rats. It was recently illustrated that these effects were established as a result of ADSC migration to the major pelvic ganglion (MPG) where these cells induced neuroregeneration in loco.AimsThe study aims to identify chemotactic factors in the MPG following injury and to match upregulated chemokines to their respective receptors in human ADSC on the genomic, structural, and functional levels.MethodsQuantitative real-time polymerase chain reaction, fluorescence-activated cell sorting (FACS), intracellular FACS, immunofluorescence microscopy, migration assays, and calcium imaging were used in this study.Main Outcome MeasuresThe main outcomes are chemokine expression in the MPG following CN injury, and the functional and structural presence of chemokine receptors in ADSC.ResultsCCR4, CX3CR1, and XCR1 are functionally and structurally present in human ADSC, and are activated by the chemokines CCL2, CX3CL1, and XCL1 respectively, which are upregulated in the MPG following CN injury. CXCR4 and its ligand CXCL12 (SDF1) are likely no major homing factors for ADSC. Expression of chemokine receptor mRNA in ADSC did not necessarily translate into receptor presence at the cell surface and/or functional activation of these receptors. Most of the expressed chemokine receptors were detected in the intracellular compartment of these cells.ConclusionsWe identified the ligand/chemokine receptor pairs CCL2/CCR4, CX3CL1/CX3CR1, and XCL1/XCR1 as potentially responsible for ADSC homing toward the MPG following CN injury. The intracellular localization of various chemokine receptors likely indicates redirecting of chemokine receptors to the cell surface under specific cellular conditions. Furthermore, modification of expression of these receptors at the genomic level may potentially lead to improved migration toward injury sites and thus enhancement of treatment efficacy. Albersen M, Berkers J, Dekoninck P, Deprest J, Lue TF, Hedlund P, Lin C-S, Bivalacqua TJ, Van Poppel H, De Ridder D, and Van der Aa F. Expression of a distinct set of chemokine receptors in adipose tissue-derived stem cells is responsible for in vitro migration toward chemokines appearing in the major pelvic ganglion following cavernous nerve injury.
机译:简介脂肪组织衍生的干细胞(ADSC)预示着其在广泛的伤害和疾病中的临床应用的巨大前景。几项临床前报告证明了它们在治疗大鼠海绵状神经(CN)损伤引起的勃起功能障碍中的功效。最近有研究表明,这些作用是由于ADSC迁移到主要盆腔神经节(MPG)而建立的,这些细胞在这些细胞中诱导了局部神经元再生。目的本研究旨在鉴定损伤后MPG中的趋化因子,并使上调的趋化因子与其匹配方法:采用定量实时聚合酶链反应,荧光激活细胞分选(FACS),细胞内FACS,免疫荧光显微镜,迁移分析和钙成像等方法对人类ADSC的各个受体进行基因组,结构和功能水平的研究。主要结果指标主要结果是CN损伤后MPG中的趋化因子表达以及ADSC中趋化因子受体的功能和结构存在。结果CCR4,CX3CR1和XCR1在人ADSC中功能和结构存在,并被趋化因子CCL2激活, CX3CL1和XCL1分别在CN受伤后在MPG中上调。 CXCR4及其配体CXCL12(SDF1)可能不是ADSC的主要归巢因素。 ADSC中趋化因子受体mRNA的表达未必转化为细胞表面的受体存在和/或这些受体的功能激活。在这些细胞的细胞内区隔中检测到大多数表达的趋化因子受体。结论我们鉴定了配体/趋化因子受体对CCL2 / CCR4,CX3CL1 / CX3CR1和XCL1 / XCR1对CN损伤后ADSC趋向于MPG有潜在的作用。各种趋化因子受体在细胞内的定位可能表明在特定细胞条件下趋化因子受体重新定向至细胞表面。此外,在基因组水平上修饰这些受体的表达可能潜在地导致向损伤部位的迁移改善,从而增强治疗功效。 Albersen M,Berkers J,Dekoninck P,Deprest J,Lue TF,Heldlund P,Lin CS,Bivalacqua TJ,Van Poppel H,De Ridder D和Van der AaF。一组不同的趋化因子受体在脂肪组织中的表达-衍生的干细胞负责在体外向海绵状神经损伤后主要骨盆神经节中趋化因子的迁移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号